Abstract. Vascular endothelial growth factor (VEGF) is a potent vascular permeability factor and a mediator of brain edema. To assess the role of vascular endothelial growth factor in eosinophilic meningitis, vascular endothelial growth factor was measured in the cerebrospinal fluid (CSF) and blood of 9 patients with eosinophilic meningitis in a cohort study. VEGF CSF was detected in 8 (90%) of 9 eosinophilic meningitis patients (range, 45-2190 pg/mL) at presentation. The mean VEGF CSF at presentation, 1 week, and 2 weeks after admission was 568 pg/mL, 751 pg/mL, and 1031 pg/mL, respectively. There was an association between VEGF CSF, CSF protein, white cell count, and eosinophil counts. The VEGF SERUM fluctuated during the 6-month follow-up period. These results indicate that vascular endothelial growth factor may be associated with blood-brain barrier disruption in patients with eosinophilic meningitis.
INTRODUCTION
Angiostrongylus cantonensis, also known as the rat lungworm, is the most common cause of eosinophilic meningitis in the Pacific Islands and Southeast Asia. Rats serve as the definitive host of the nematode. If an infection occurs in nonpermissive hosts, including humans and mice, the development of the parasites will terminate at the young-adult worm stage in the brain and cause eosinophilic meningitis or meningoencephalitis. [1] [2] [3] [4] Several indices have been developed to assess the blood-brain barrier (BBB) integrity in an individual with a central nervous system infection. It was reported that most human immunodeficiency virus (HIV)-infected patients have pathologic cerebrospinal fluid (CSF) findings for at least one parameter, such as an elevated CSF total protein level, CSF white blood cell count, or CSF serum Immunoglobulin G ratio. 5 In a mice animal model of eosinophilic meningitis caused by A. cantonensis infection, researchers showed that dysfunction of the BBB occurred in mice infected with A. cantonensis, evidenced by the high concentrations of protein and albumin, high leukocyte counts in CSF, high ratio of CSF/serum protein and albumin, and high permeability of BBB. 6 Infection of the CSF causes a severe inflammatory reaction, mediated by pathogen products and host cytokines. This inflammatory reaction compromises the function of BBB, resulting in the exudation of plasma proteins and development of vasogenic brain edema, which contributes to cerebral dysfunction and brain damage. 7 Vascular endothelial growth factor (VEGF), a 46-kDa glycosylated homodimeric protein, is a regulator of angiogenesis and a potent inducer of vascular permeability. 8 VEGF is implicated in the pathogenesis of brain edema related to ischemia, trauma, bacterial meningitis, tuberculous meningitis, and tumors. 7, 9, 10 To assess the role of VEGF in the pathophysiology of eosinophilic meningitis, dynamic VEGF levels were measured in CSF and serum of patients with eosinophilic meningitis in our cohort study.
MATERIALS AND METHODS

Patients.
A case of eosinophilic meningitis was clinically defined as presentation with an acute onset of headache, eosinophil pleocytosis in the blood/CSF, accompanied by at least of one of the following: fever, ataxia, visual disturbances, photophobia, nuchal rigidity, neck pain, hyperesthesias, or paresthesias. 11 Three outbreaks of eosinophilic meningitis, caused by A. cantonensis occurred in Kaohsiung, Taiwan, in 1998, 1999, and 2001. [11] [12] [13] Most of the patients (77%) were adult, male, Thai laborers who had eaten raw golden apple snails within 3 weeks. Study subjects were derived from the second outbreak in 1999. 12, 13 All of the 9 Thai laborers received only analgesics or glycerol as treatment (or both). Each patient underwent a physical, neurologic, and ophthalmic examination. Laboratory tests were performed at the time of admission and spinal taps were performed on all patients. CSF analysis included cell count, glucose and protein levels, gram and acid-fast stains, India ink preparation, wet mount preparations for larvae, and measurement of cryptococcal antigen. The patients were observed daily during their hospital course. CSF was examined weekly until discharge. Blood was obtained weekly for the first 2 months, every other week for the next 2 months, and monthly thereafter for as long as 6 months. Blood and CSF samples were centrifuged (1700 g at 4°C) immediately, aliquoted, and stored at − 70°C.
Antibodies to A. cantonensis were detected in serum and CSF by a microenzyme-linked immunosorbent assay (ELISA) using young-adult worm antigen, with a molecular weight 204kD, and purified by monoclonal antibody.
14 Vascular endothelial growth factor measurements. Levels of VEGF in the serum and CSF (VEGF SERUM and VEGF CSF, respectively) were measured by enzyme immunoassay (Neogen Corporation, Lansing, MI). This Neogen's Sandwich Human VEGF is a sandwich enzyme immunoassay (EIA), which measures the free forms of the cytokine VEGF 165. Mouse monoclonal antibodies generated against human VEGF were used to capture human VEGF in a sample. Simultaneously, biotinylated rabbit anti-human VEGF polyclonal antibodies detected VEGF in the sample. The assay was visualized using a streptavidin alkaline phosphatase conjugate and an ensuring chromogenic substrate reaction. The assay sensitivity was 26.6 pg/ml, the range of de-tection 40.0 pg/ml to 5000 pg/ml, cross-reactivity < 0.5% against cytokine standards, intra-assay variation ± 7.3%, and inter-assay variation ± 10.5%. For patients with undetectable VEGF level, an arbitrary level of 25 pg/ml was used for statistical purpose.
Statistical analysis. The association between VEGF and CSF laboratory abnormalities was analyzed with Pearson correlation test. A P value < 0.05 was considered statistically significant. He recovered without treatment in about a week. The serial changes of VEGF CSF were 595 pg/mL at presentation, 160 pg/mL and 3250 pg/mL one and two weeks after admission, and 3640 pg/mL at recurrence of headache. VEGF CSF was detected in 8 (90%) of 9 eosinophilic meningitis patients (range, 45-2190 pg/mL) at presentation. The mean VEGF CSF at presentation, 1 week, and 2 weeks after admission was 568 pg/mL, 751 pg/mL, and 1031 pg/mL, respectively. The VEGF SERUM fluctuated during the 6-month follow-up. The mean CSF protein was 131 mg/dl at presentation and dropped to 81 mg/dl 2 weeks later. One patient had a rebound CSF protein level (141 mg/dl) on fifth lumbar puncture done 4 weeks later. CSF white cell count showed a time-dependent decrease, with mean levels of 618 cumm/ml, 320 cumm/ml, and 433 cumm/ml at presentation, 1 week, and 2 weeks after admission, respectively. The CSF white cell counts done during the fourth and fifth lumbar puncture in the two patients with recurrent headache were 369 cumm/ml and 667 cumm/ml, respectively. There was an association between VEGF CSF , total CSF protein concentrations, white cell counts, and eosinophil counts (Table 1) .
RESULT
DISCUSSION
In this study, we showed that VEGF CSF was detected in 8 (90%) of 9 eosinophilic meningitis patients (range, 45-2190 pg/mL) at presentation. There was an association between VEGF CSF, CSF protein, white cell count, and eosinophil counts. These results indicate that VEGF may play a role in the pathophysiology of eosinophilic meningitis. An increase in leukocyte count can be observed in the CSF of patients with central nervous system infection due to BBB damage. 15, 16 Our result showed that CSF white cell count had a time-dependent decrease, with mean levels of 618 cumm/ml, 320 cumm/ml, and 433 cumm/ml at presentation, 1 week, and 2 weeks after admission, respectively. The high white cell count in the CSF represented that the transmigration of leukocytes from the peripheral blood to the CSF in human infected with A. cantonensis becomes easier due to the presence of BBB dysfunction. The time-dependent decrease in CSF white cell count is compatible with the study by DortaContreras and others, 17 which showed that at the time of early clinical recovery, the blood-CSF barrier dysfunction was normalized in 75% of the patients. The CSF protein was elevated in our patients with eosinophilic meningitis. In the study of Yii, 4 CSF protein was higher in patients with A. cantonensisinduced eosinophilic meningitis than the normal human. The explanation for an increase in CSF protein concentrations include a decreasing CSF flow rate 18 and appearance of plasma proteins in the CSF due to presumed or overt disruption of blood-CSF barrier. 19 Furthermore, Dorta-Contreras and others 17 demonstrated that during the first 3 days of acute phase of eosinophilic meningoencephalitis, a blood-CSF barrier dysfunction occurred, usually due to a reduced CSF flow rate. Taken together, VEGF is associated with blood-brain barrier dysfunction in patients with eosinophilic meningitis.
Previous reports showed that VEGF can induce endothelial changes during bacterial meningitis, including increased vesicle transport and separation of endothelial intercellular tight junctions. Exposure of normal rat brain to VEGF results in BBB disruption, and VEGF is implicated in the formation of cerebral edema. 9, 20 Additionally, dexamethasone, which is used as adjunctive therapy in bacterial meningitis, suppresses tumor-associated brain edema by a mechanism involving downregulation of VEGF expression. 21, 22 Corticosteroid is also used as an adjunctive therapy in eosinophilic meningitis. Whether it is also mediated by a mechanism involving downregulation of VEGF expression still unknown. In the clinical study of Chotmongkol and others, 23 a 2-week course of prednisolone was beneficial in relieving the headache in patients with eosinophilic meningitis. In another study, researchers 24 showed that a 1-week course of corticosteroid had the same beneficial effect as a 2-week course in increasing the number , VEGF CSF3 , represent the CSF VEGF level at presentation (n ‫ס‬ 7), 1 week (n ‫ס‬ 9), and 2 weeks later (n ‫ס‬ 6). CSF protein 1, CSF protein 2, CSF protein 3 are the protein concentration in CSF at presentation, 1 week, and 2 weeks after admission. CSF wbc1, CSF wbc2, CSF wbc3 show the white cell count in CSF at presentation, 1 week, and 2 weeks later. CSF eosin represented CSF eosinophil counts at presentation. * showed P < 0.05.
of patients who felt free from headache. In our study, VEGF CSF measured 1 and 2 weeks after presentation was significantly correlated with CSF abnormalities. The time course is consistent to the clinical treatment duration for 1 or 2 weeks, although we did not use any steroids in our patients. One of our patients with recurrent headache received glycerol as an adjuvant therapy. Osmotherapy with mannitol, glycerol, or hypertonic saline is often used in patients with severe brain edema after stroke or neurotrauma. 25 It can result in massive osmotic diuresis and fluid and electrolytes imbalance. As a result of a disrupted blood-brain barrier, the osmotic agents may leak into the brain parenchyma, with further disturbance of the osmotic gradient as a result. 25 Interestingly, osmotherapy may even enhance disturbance of the blood-brain barrier. Mannitol cause the shrinkage of cerebral capillaries resulting in the opening of endothelial tight junction. 26 This osmotic stress can involve in the calcium influx, nitric oxide, and cytoskeletal changes [26] [27] [28] and probably influence the measurement of VEGF in CSF.
The finding that VEGF CSF could not be detected in the CSF of all our patients with eosinophilic meningitis may be explained in several ways. First, locally secreted VEGF may induce endothelial permeability via the luminal receptors of endothelial cells, and may not be reflected in the CSF level. Disruption of the BBB may be further aggravated by VEGF secreted in the CSF via the abluminal receptors of endothelial cells. 7, 9 Second, the timing of sampling may affect VEGF CSF detection because the in vivo half-life of VEGF CSF is unknown. 7 Third, not every patient in our study had CSF abnormalities. Finally, BBB disruption during eosinophilic meningitis involves a complex interaction between eosinophils and mediators, such as interleukin-4, interleukin-5, plateletactivating factor, nitric oxide, and matrix metalloproteinases, which might induce BBB permeability, independent of VEGF. 29 We did not measure the serum/CSF albumin for VEGF index. VEGF levels were higher in the serum compared with the CSF, therefore the possibility of VEGF accumulation in CSF caused by passive influx instead of intrathecal production can not be excluded. However, it remains to be determined whether this is due to a fairly low production of VEGF by inflammatory cells, rapid degradation of immunoreactive VEGF, or binding of VEGF to soluble or cell-bound VEGF receptors. 30 Based on our small cases series, we found that patients with eosinophilic meningitis and presence of VEGF proteins in CSF could be associated with disruption of BBB. There was an association between VEGF CSF, CSF protein, white cell count, and eosinophil counts. The VEGF SERUM fluctuated during the 6-month follow-up period. However, larger cases studies are needed to justify this conclusion.
